Want to see DE:GME full AI Analyst Report?

Geratherm Medical (GME) Price & Analysis

10 Followers

GME Stock Chart & Stats

€2.86

-€0.08(-2.22%)

At close: Jan 09 4:00 PM EST

€2.86

-€0.08(-2.22%)

Day’s Range― - ―

52-Week Range€1.95 - €4.69

Previous CloseN/A

Volume28.00

Average Volume (3M)624.00

Market Cap

€11.49M

Enterprise Value€7.55M

Total Cash (Recent Filing)€8.81M

Total Debt (Recent Filing)€2.19M

Price to Earnings (P/E)―

Beta0.59

Next Earnings

Apr 27, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.74%

Share Statistics

EPS (TTM)-0.14

Shares Outstanding5,444,998

10 Day Avg. Volume691

30 Day Avg. Volume624

Financial Highlights & Ratios

PEG Ratio0.09

Price to Book (P/B)0.80

Price to Sales (P/S)1.05

P/FCF Ratio12.78

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.02

Revenue Forecast (FY)€15.00M

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a substantial equity base provide financial flexibility during the current loss-making period. This conservative capital structure can help Geratherm absorb earnings volatility, preserve funding capacity, and support continued operations without relying heavily on additional borrowing.

Positive Cash GenerationPositive operating and free cash flow show that the business is still converting its activities into cash despite weaker profitability. This supports ongoing investment and working-capital needs, while reducing immediate dependence on external financing over the coming quarters.

Strong Gross MarginA gross margin near 67% indicates meaningful value capture at the product level across Geratherm's medical-device portfolio. If maintained, this provides a foundation for restoring operating profitability when revenue stabilizes or operating costs become better absorbed.

Bears Say

Severe Revenue WeaknessThe sharp reported revenue decline and highly volatile trend weaken the scale of Geratherm's operations and make fixed-cost absorption more difficult. Continued top-line instability could limit investment capacity and prevent the company from converting its strong gross margin into sustainable earnings.

Return To LossesThe return to negative net and operating margins demonstrates that current sales are not producing sustainable profitability. Losses can erode equity over time, constrain internally funded growth, and make future performance more dependent on a successful recovery in revenue and operating execution.

Deteriorating Cash FlowAlthough cash flow remains positive, the sharp decline in free cash flow reduces confidence in its durability. Weaker conversion means less cash is available for product development, distribution expansion, or shareholder returns, increasing the importance of reversing the recent operating deterioration.

GME FAQ

What was Geratherm Medical AG’s price range in the past 12 months?

Geratherm Medical AG lowest stock price was €1.95 and its highest was €4.69 in the past 12 months.

What is Geratherm Medical AG’s market cap?

Geratherm Medical AG’s market cap is €11.49M.

When is Geratherm Medical AG’s upcoming earnings report date?

Geratherm Medical AG’s upcoming earnings report date is Apr 27, 2027 which is in 179 days.

How were Geratherm Medical AG’s earnings last quarter?

Geratherm Medical AG released its earnings results on Aug 27, 2026. The company reported -€0.08 earnings per share for the quarter.

Is Geratherm Medical AG overvalued?

According to Wall Street analysts Geratherm Medical AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Geratherm Medical AG pay dividends?

Geratherm Medical AG pays a Annually dividend of €0.1 which represents an annual dividend yield of 4.74%. See more information on Geratherm Medical AG dividends here

What is Geratherm Medical AG’s EPS estimate?

Geratherm Medical AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Geratherm Medical AG have?

Geratherm Medical AG has 5,444,998 shares outstanding.

What happened to Geratherm Medical AG’s price movement after its last earnings report?

Geratherm Medical AG reported an EPS of -€0.08 in its last earnings report. Following the earnings report the stock price went up 0.806%.

Which hedge fund is a major shareholder of Geratherm Medical AG?

Currently, no hedge funds are holding shares in DE:GME

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Geratherm Medical Stock Smart Score

Underperform

Technicals

Fundamentals

Return on Equity

-4.38%

Trailing 12-Months

Asset Growth

-7.22%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Geratherm Medical AG

Geratherm Medical AG, a German-based medical technology enterprise, organizes its operations across four primary divisions: Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems. The Healthcare Diagnostic unit offers a range of items including clinical thermometers, blood pressure monitors, and various self-test diagnostic products designed for women, such as pregnancy tests, chlamydia screens, urinary tract infection indicators, diverse ovulation solutions, and pH tests. Its Respiratory segment is dedicated to the development and production of equipment primarily for diagnosing pulmonary and cardiopulmonary function. Under the LMT brand, the Medical Warming Systems division manufactures MRI-compatible incubators for premature and newborn infants. The Cardio/Stroke segment provides analytical products aimed at assessing stroke risk by detecting atrial fibrillation. The company markets its healthcare solutions via pharmacies, hospitals, and clinics, and successfully exports its merchandise to approximately 60 nations worldwide. Established in 1990, Geratherm Medical AG's headquarters are situated in Geschwenda, Germany.